Association of serum interferon‐λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct‐acting antiviral agents

Aim Although the efficacy of hepatitis C virus (HCV) treatment is improved dramatically by direct‐acting antiviral agents (DAAs), the assessment of hepatocellular carcinoma (HCC) remains important. Interferon lambda 3 (IFN‐λ3) is associated with liver fibrosis and inflammation in chronic hepatitis C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology research 2019-05, Vol.49 (5), p.500-511
Hauptverfasser:	Inoue‐Shinomiya, Emi, Murakawa, Miyako, Asahina, Yasuhiro, Nakagawa, Mina, Tsuchiya, Jun, Sato, Ayako, Tsunoda, Tomoyuki, Miyoshi, Masato, Nitta, Sayuri, Kawai‐Kitahata, Fukiko, Itsui, Yasuhiro, Azuma, Seishin, Kakinuma, Sei, Murata, Kazumoto, Mizokami, Masashi, Watanabe, Mamoru
Format:	Artikel
Sprache:	eng
Schlagworte:	Alanine Alanine transaminase Antiviral agents Carcinogenesis Chemiluminescence direct‐acting antiviral agent Enzyme immunoassay Fibrosis Gene polymorphism HCC Hepatitis Hepatitis C hepatitis C virus Hepatocellular carcinoma Interferon interferon‐λ3 Liver Nodules SVR
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!